IOİlTer Ozer

İlTer Ozer

*This is an algorithmically generated author record based on publicly available information.

İlTer Ozer has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Effect of Local Papaverine Use in an Experimental High-Risk Colonic Anastomosis Model: Reduced Inflammatory Findings and Less Necrosis

    by Dursun Burak Ozdemir, Ahmet Karayigit, Emel Tekin, Evin Kocaturk, Cengiz Bal, Ilter Ozer

    Objectives: To assess the impact of topical papaverine administration in complete and incomplete colonic anastomosis, by examining bursting pressure, hydroxyproline concentration, collagen content, inflammation levels, inflammatory cell infiltration, neoangiogenesis, and necrosis grades. Methods: We performed an experimental study on rats, in which they were divided into the following 4 groups of 16 subjects each. Group 1 [complete anastomosis (CA) without papaverine (CA -P) group], Group 2 [CA with papaverine (CA +P) group], Group 3 [incomplete anastomosis (ICA) without papaverine (ICA -P) group], and Group 4 [ICA with papaverine (ICA +P) group]. Results: The lymphocyte infiltration score of the ICA +P3 (day 3) group was significantly higher compared to the ICA -P3 group (p = 0.018). The median Ehrlich–Hunt score (p = 0.012), inflammation score (p = 0.026), and neutrophil infiltration score (p = 0.041) of the CA +P7 (day 7) group were significantly lower than the corresponding data of the CA -P7 group. Additionally, the necrosis score of the ICA +P7 group was significantly lower than that of the ICA -P7 group (p = 0.014). Conclusions: Data from the current study reveal that, although topical papaverine seems to suppress inflammation in anastomosis tissue and reduce necrosis at 7 days, definite conclusions regarding its impact on anastomotic leak cannot be drawn without further studies investigating anastomotic wound healing and anastomotic leak, preferably with both shorter- and longer-term evaluations.


  • Open Access

    Primary neuroendocrine tumor of the perihilar bile duct: A case report

    by Mustafa Salış, Muhammed Kandemir, Elif Gündoğdu, İlTer Özer, Bülent Ünal, Murat Ulaş

    Neuroendocrine tumors (NETs) arising from extrahepatic bile ducts are very rare. We present a patient with perihilar NET who was operated on with a preoperative diagnosis of Klatskin tumor. A 58-year-old female patient was admitted with abdominal pain and jaundice. Laboratory data showed elevated serum bilirubin levels and liver function tests. Computed tomography (CT) and magnetic resonance cholangiopancreatography (MRCP) findings were consistent with perihilar bile duct tumor. The patient was operated on with a diagnosis of Klatskin tumor. She underwent right hepatectomy, resection of the extrahepatic bile duct, portal lymphadenectomy and Roux-en-Y hepaticojejunostomy. The final pathologic examination of the resected specimen demonstrated a well differentiated neuroendocrine tumor (Grade 1). NETs originating from perihilar bile ducts are extremely rare, and preoperative definite diagnosis is very difficult. It should be kept in mind that NET may be one of the rare causes of perihilar bile duct obstruction.

  • Open Access

    Significance of High-Mobility Group A Protein 2 Expression in Pancreatic Ductal Adenocarcinoma and Ampullary Adenocarcinoma

    by Damla Oflas, Funda Canaz, İlTer Özer, Lütfiye Demir, Ertuğrul Çolak

    Background/Aims: Pancreatic and ampullary adenocarcinoma (AAC) are quite resistant to chemotherapy with high metastasis potential. Our study aimed to interpret high-mobility group A protein 2 (HMGA2) expression in benign and precursor pancreatic lesions and pancreatic and ampullary carcinoma and to evaluate its relationship with epithelial–mesenchymal transition (EMT) and clinicopathological parameters. Materials and Methods: In this study, normal-appearing pancreas, chronic pancreatitis (CP), low- (L) and high (H)-grade pancreatic intraepithelial neoplasia (PanIN), pancreatic ductal adenocarcinoma (PDAC), and AAC were evaluated with the immunohistochemical marker of HMGA2. Vimentin and E-cadherin immunohistochemical stains were applied in PDAC and AAC. Results: The HMGA2 expression was not detected in normal-appearing pancreas, CP, and L-PanIN. A statistically significant expression was observed in PDAC and H-PanIN (P < .001). A statistically significant correlation was found between loss of membranous E-cadherin expression and vimentin positivity and HMGA2 expression (P > .05). The HMGA2 expression was observed to increase the risk of diseaserelated death and decrease overall survival (OS) in AAC and the neoplasia group (P = .002 and P = .016, respectively). There was no significant difference in OS and risk of death in PDAC (P > .05) with respect to HMGA2 positivity. Conclusion: High-mobility group A protein 2 is a helpful immunohistochemical marker in differentiating CP from PDAC. It also plays a role in EMT and may serve as a potential new prognostic agent and therapeutic target in tumors of the periampullary region, especially AAC. Cite this article as: Oflas D, Canaz F, Özer İ, Demir L, Çolak E. Significance of high-mobility group A protein 2 protein expression in pancreatic ductal adenocarcinoma and ampullary adenocarcinoma. Turk J Gastroenterol. 2023;34(10):1014-1024.


  • Open Access

    Main Portal Vein Diameter Changes in Patients Undergoing Gastric Surgery for Malignancy: An Observational CT Study

    by Elif Gündoğdu, Fatma Didem Bayav, İhSan Burak Karakaya, Barış Türker, İlTer Özer

    Background In the follow-up computed tomography (CT) examinations of patients who had undergone gastrectomy for gastric malignancy in our center, we noticed by chance that there was an isolated increase in the diameter of the main portal vein (MPV) without other radiological findings of portal hypertension. Objectives In this study, we aimed to evaluate whether the MPV diameter of patients who had gastric surgery for malignancy differed in the preoperative and postoperative periods and its change over time in patients who underwent postoperative follow-up examinations. Materials and Methods The CT images of 240 patients who underwent abdomen CT for staging and follow-up gastric malignancy between January 2017 and September 2021 were evaluated retrospectively. The CT scans of the remaining 149 patients after the exclusion criteria were included in the study. All CT imaging was performed using multidetector CT (64 or 128 slice) in portal venous phases. The images were evaluated by two radiologists based on consensus. Maximum MPV diameter were measured outer wall to outer wall with calipers on axial images at the level of 1 cm distal to the portosplenic confluence. Results One hundred forty-nine patients included in the study had preoperative CT examination. Eighty-three patients had follow-up CT examination at third month, 89 patients at sixth month, and 99 patients at first year. The MPV diameters differed significantly between preoperative CT and postoperative third month, sixth month, and first year CT (p = 0.001, p = 0.001, and p = 0.001, respectively). There was no difference in MPV diameter between postoperative third month CT and postoperative 6th month and 1st year CT (p = 0.514 and p = 0.078, respectively). Conclusion There is an increase in MPV diameter in the first 3 months postoperatively in patients undergoing gastric surgery for malignancy. This enlargement continues unchanged in the first 1 year follow-up. The radiologists' awareness of this situation may prevent the wrong diagnosis of portal hypertension, unnecessary concern, and further investigation.

  • Lateral lymph node involvement presents another challenge in rectum cancer in the age of neoadjuvant chemoradiotherapy + total mesorectal excision: an evaluation of survival outcomes

    by Ümit Özdemir, Elif Gündoğdu, Melek Yakar, Funda Canaz, Murat Ulaş, İlTer Özer

    Purpose In the last decades, total mesorectal excision (TME) and neoadjuvant chemoradiotherapy (nCRT) have produced an undeniable improvement in the treatment of rectal cancer. However, local recurrence is still an important problem, and the effect of lateral lymph node (LLN) involvement on local recurrence is a controversial issue. The aim of this study was to investigate the effects of LLN status on local recurrence and survival in rectal cancers treated with nCRT + TME. Methods Clinical features, pre- and post-nCRT lateral pelvic region imaging, long-term local recurrence, and the survival outcomes of 114 patients who underwent nCRT + TME for rectal cancer were evaluated. Results On MRI before nCRT, 20 (17.5%) patients had lateral lymph nodes (LLN+), and 94 (82.5%) patients had no lymph nodes in the lateral pelvic compartments (LLN−). Local recurrences at 1 year in LLN+ and LLN− patients were 3 (15.8%) and 2 (2.3%), respectively (p=0.039). Five-year local recurrence-free survival rates and the mean duration of recurrence-free survival in LLN+ and LLN− patients were 56.2%, 42.6 months, and 87.3% 66.9 months, respectively (p=0.001). Disease-free survival and overall survival were shorter in LLN+ patients, but the difference was not statistically significant (p=0.096 and p=0.46, respectively). In the multivariate analysis, LLN involvement was determined to be an independent risk factor for local recurrence-free survival (Hazard Ratio 4.54, p=0.003). Conclusion Lateral lymph node involvement causes local recurrence to remain high after nCRT + TME. LLN status should be considered in treatment planning. Further studies are needed to define precise criteria for LLN involvement and the effect of LLND on local recurrence and survival.


  • ÜÇ YILDA YAPILAN KOLOREKTAL KANSER AMELİYATLARININ DEĞERLENDİRİLMESİ

    by Dursun Burak Özdemi̇r, Ahmet Karayi̇ğİt, Hayrettin Di̇zEn, Ümit Özdemi̇r, İhSan Karakaya, Barış TÜRKER, Cüneyt Akyüz, Murat Ulaş, İlTer Ozer, Bülent Ünal

    Amaç: Bu çalışma, laparoskopik veya açık cerrahi uygulanan kolorektal kanserli hastaların klinikopatolojik özelliklerini, cerrahi özelliklerini ve kısa dönem sonuçlarını sunmayı amaçlamıştır. Gereç Ve Yöntem: Ocak 2017 ile Aralık 2020 tarihleri arasında XXX Genel Cerrahi Anabilim Dalı'nda ameliyat edilen kolorektal kanser olgularının verileri retrospektif olarak incelendi. Tümör lokalizasyonu, patolojik tanılar, operasyon tipleri, tümör, tümör invazyonu, lenf nodu özellikleri, ek tedaviler, hemogram testleri, hastanede kalış süresi, takip süresi, postoperatif komplikasyonlar, nüks ve mortalite analiz edildi. Bulgular: Hastaların yaşları ortanca 66 olmak üzere 36 ile 87 arasındaydı. Olguların %79,55'inde açık cerrahi, %20,45'inde laparoskopik cerrahi uygulandı. Ortalama hastanede kalış süresi 6 gündü (IQR: 5-8). Ortalama takip süresi 20.52 ± 10.49 aydı. Olguların %16.67'sinde ameliyat sonrası enfeksiyon, %6.82'sinde ameliyat sonrası kaçak gözlendi. Altı hastada (%5.61) nüks görüldü. Mortalite oranı %17,41, erken mortalite (≤30 gün) oranı ise %3,03 idi. Sonuç: Laparoskopik ve açık kolorektal cerrahi ile ilgili daha fazla yayına ihtiyaç vardır. Kliniklerin kolorektal cerrahide elde ettikleri sonuçları ve deneyimlerini paylaşmalarının önemli olduğunu, sonuçlarımızın literatüre katkı sağlayacağının yanı sıra ülkemizde giderek yaygınlaşan genel cerrahi kliniklerinin kurulmasına da katkı sağlayacağına inanıyoruz.

  • Open Access

    Venöz rezeksiyonlu pankreatikoduodenektomi sonuçları: 11 olgu ile tek merkez deneyimi

    by Dursun Burak Özdemi̇r, Ahmet Karayi̇ği̇t, Hayrettin Di̇zen, Ümit Özdemi̇r, İhsan Burak Karakaya, Barış TÜRKER, Cüneyt Akyüz, Murat Ulaş, İlter Ozer, Bülent Ünal

    Aim: To perform a retrospective evaluation of the morbidity and mortality rates and reliability of venous resection with pancreaticoduodenectomy (PD) procedures in our clinic. Material and Method: The records of 11 patients who underwent PD with venous resection between May 2016 and May 2021 in the Eskişehir Osmangazi University Faculty of Medicine Department of General Surgery were analyzed retrospectively. Results: Eleven patients (five women and six men) were included. The patients’ mean age was 64.09±9.27 years (range 47-78). Four (36.36%) patients underwent type 1 reconstruction, one (9.09%) type 2 reconstruction, five (45.45%) type 3 reconstruction and one (9.09%) type 4 reconstruction. Eight (72.73%) patients experienced venous invasion according to the histopathology reports. Mean time between diagnosis and surgery was 14.91±11.33 days, and the mean follow-up time was 17.64±13.31 months. Grade C pancreatic fistula was observed in one (9.09%) patient, who died on the 17th postoperative day. No patients experienced recurrence or metastasis during surveillance. Conclusion: Pancreaticoduodenectomy with venous resection-reconstruction is safe and the only curative option in patients with pancreatic cancer and venous invasion.

  • Milky White Lipid Solution Injection Through Cystic Duct to Recognise Biliary Hydatid Fistula — an Innovative Technique

    by Ahmet Karayigit, Hayrettin Dizen, Dursun Burak Ozdemir, Ilter Ozer, Bulent Unal

  • Open Access

    Role of red cell dstribution width in colorectal cancer diagnosis and prognosis

    by Ahmet Karayi̇ğİt, Dursun Burak Özdemi̇r, Hayrettin Di̇zEn, Bülent Ünal, İlTer Ozer, Murat Ulaş

    Objective: We aimed to assess whether red cell distribution width (RDW) was associated with pre-operative clinical features or post-operative clinicopathological outcomes in patients with colorectal cancer (CRC), and to determine the utility of RDW as a diagnostic or prognostic marker of CRC. Material and Method: This retrospective cohort study was conducted between January 2018 and May 2021 at a university hospital in Turkey. A total of 188 patients histologically diagnosed with CRC who had undergone surgery were included in the study. Results: Our study included 118 (62.77%) male patients, and the mean age of the patients was 66.28±11.71 years. We found that RDW values were significantly higher in females compared to males (p=0.033), in patients with T3 or T4 tumors compared to those with T1 or T2 tumors (p